Fundamentals of Membrane Lipid Replacement: A Natural Medicine Approach to Repairing Cellular Membranes and Reducing Fatigue, Pain, and Other Symptoms While Restoring Function in Chronic Illnesses and Aging
Source abstract
Abstract
Membrane Lipid Replacement (MLR) uses natural membrane lipid supplements to safely replace damaged, oxidized lipids in membranes in order to restore membrane function, decrease symptoms and improve health. Oral MLR supplements contain mixtures of cell membrane glycerolphospholipids, fatty acids, and other lipids, and can be used to replace and remove damaged cellular and intracellular membrane lipids. Membrane injury, caused mainly by oxidative damage, occurs in essentially all chronic and acute medical conditions, including cancer and degenerative diseases, and in normal processes, such as aging and development. After ingestion, the protected MLR glycerolphospholipids and other lipids are dispersed, absorbed, and internalized in the small intestines, where they can be partitioned into circulating lipoproteins, globules, liposomes, micelles, membranes, and other carriers and transported in the lymphatics and blood circulation to tissues and cellular sites where they are taken in by cells and partitioned into various cellular membranes. Once inside cells, the glycerolphospholipids and other lipids are transferred to various intracellular membranes by lipid carriers, globules, liposomes, chylomicrons, or by direct membrane–membrane interactions. The entire process appears to be driven by ‘bulk flow’ or mass action principles, where surplus concentrations of replacement lipids can stimulate the natural exchange and removal of damaged membrane lipids while the replacement lipids undergo further enzymatic alterations. Clinical studies have demonstrated the advantages of MLR in restoring membrane and organelle function and reducing fatigue, pain, and other symptoms in chronic illness and aging patients.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Diet and metabolism studies · Fatty Acid Research and Health · Vitamin C and Antioxidants Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA 92647, USA
Laboratory of Ion Channels, Biological Membranes and Cell Signaling, Department of Biophysics, Facultad de Medicina, Universidad de la República, Montevideo 11600, Uruguay
Clinical Education, Newton Abbot, Devon TQ12 4SG, UK
Sierra Productions Research, Mission Viejo, CA 92612, USA
Laboratory of Molecular Cell Biomedicine, University of the Balearic Islands, 07122 Palma de Mallorca, Spain
References (100+)
Show source-provided references
1. Membrane Lipid Replacement for chronic illnesses, aging and cancer using oral glycerolphospholipid formulations with fructooligosaccharides to restore phospholipid function in cellular membranes, organelles, cells and tissues10.1016/j.bbamem.2017.04.013 ↗
2. Membrane Lipid Replacement: Clinical studies using a natural medicine approach to restoring membrane function and improving health10.4236/ijcm.2016.72015 ↗
3. Clinical uses of Membrane Lipid Replacement supplements in restoring membrane function and reducing fatigue in chronic illnesses and cancer10.15190/d.2016.1 ↗
4. Membrane-lipid therapy: A new approach in molecular medicine10.1016/j.molmed.2005.11.004 ↗
5. The effect of natural and synthetic fatty acids on membrane structure, cellular functions and human health10.1016/j.bbamem.2013.12.021 ↗
6. Gundermann, K.J. (1993). The “Essential” Phospholipids as a Membrane Therapeutic, European Society of Biochemical Pharmacology.
7. Health effects of dietary phospholipids10.1186/1476-511X-11-3 ↗
8. Lipids on the frontier: A quarter century of cell-membrane bilayers10.1038/nrm1102 ↗
9. Membrane lipids: Where they are and how they behave10.1038/nrm2330 ↗
10. Role for membrane in cell death: Implication for health and disease10.1016/j.tox.2012.12.014 ↗
11. G protein-membrane interactions: Gai1 myristoyl and palmitoyl modifications in protein-lipid interactions and its implications in membrane microdomain localization10.1016/j.bbalip.2015.08.001 ↗
12. Membranes: A meeting point for lipids, proteins and therapies10.1111/j.1582-4934.2008.00281.x ↗
13. Diseases related to oxygen-derived free radicals
14. Free radicals in disease processes: A compilation of cause and consequence10.3109/10715769309111598 ↗
15. Aging: A theory based on free radical and radiation chemistry10.1093/geronj/11.3.298 ↗
16. Oxygen free radicals and human diseases10.1177/146642409111100506 ↗
17. Lipid peroxidation modifies the picture of membranes from the “Fluid Mosaic Model” to the “Lipid Whisker Model”10.1016/j.biochi.2011.09.025 ↗
18. Oxidative damage and mitochondrial decay in aging10.1073/pnas.91.23.10771 ↗
19. Bioenergetics and the formation of mitochondrial reactive oxygen species10.1016/j.tips.2006.10.005 ↗
20. Oxidative stress, mitochondrial DNA mutation and impairment of antioxidant enzymes in aging10.1177/153537020222700901 ↗
21. Stress-response hormesis and aging: That which does not kill us makes us stronger10.1016/j.cmet.2008.01.001 ↗
22. Mitochondrial dysfunction in brain aging: Role of oxidative stress and cardiolipin10.1016/j.neuint.2010.12.016 ↗
23. Leveraging oxidative stress questions in vivo: Implications and limitations10.1016/j.abb.2015.11.009 ↗
24. The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy10.1007/s00415-004-0348-9 ↗
25. Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities10.1089/ars.2009.2668 ↗
26. (2006). Halliwell, Oxidative stress and neurodegeneration: Where are we now?. J. Neurochem., 97, 1634–1658.10.1111/j.1471-4159.2006.03907.x ↗
27. Identification of a lipid peroxidation product as a potential trigger of the p53 pathway10.1074/jbc.M509065200 ↗
28. Intestinal absorption of polyenephosphatidylcholine in Man10.1016/S0022-2275(20)38050-0 ↗
29. Morphologic aspects of lipid absorption10.1093/ajcn/22.3.257 ↗
30. Intestinal lipid absorption10.1152/ajpendo.90899.2008 ↗
31. Lipid digestion and absorption10.1146/annurev.ph.45.030183.003251 ↗
32. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process10.1083/jcb.121.6.1257 ↗
33. Ferreira, G., Costa, C., Bassaizteguy, V., Santos, M., Cardozo, R., Montes, J., Settineri, R., and Nicolson, G.L. (2018). Incubation of human sperm with micelles made from glycerophospholipid mixtures increases sperm motility and resistance to oxidative stress. PLoS ONE, 13.10.1371/journal.pone.0197897 ↗
34. Lipidomics: Coming to grips with lipid diversity10.1038/nrm2934 ↗
35. Biophysical properties of lipids and dynamic membranes10.1016/j.tcb.2006.08.009 ↗
36. Nicolson, G.L., and Ferreira de Mattos, G. (2021). A brief introduction to some aspects of the Fluid—Mosaic Model of cell membrane structure and its importance in Membrane Lipid Replacement. Membranes, accepted.10.3390/membranes11120947 ↗
37. Lagoutte-Renosi, J., Allemand, F., Ramseyer, C., Rabani, V., and Davani, S. (2021). Influence of anti-platent agents on the composition of platelet plasma membrane: A lipidomics approach with ticagrelor and its active metabolite. Intern. J. Mol. Sci., 22.10.3390/ijms22031432 ↗
38. Structural aspects of ganglioside-containing membranes10.1016/j.bbamem.2008.11.003 ↗
39. Lipid asymmetry in membranes10.1146/annurev.bi.48.070179.000403 ↗
40. An outlook on organization of lipids in membranes: Searching for a realistic connection with the organization of biological membranes10.1016/j.plipres.2010.05.001 ↗
41. The liquid-ordered phase in membranes10.1016/j.bbamem.2008.08.005 ↗
42. The Fluid Mosaic Model of the structure of cell membranes10.1126/science.175.4023.720 ↗
43. The Fluid—Mosaic Model of membrane structure: Still relevant to understanding the structure, function and dynamics of biological membranes after more than forty years10.1016/j.bbamem.2013.10.019 ↗
44. Functional rafts in cell membranes10.1038/42408 ↗
45. Revitalizing membrane rafts: New tools and insights10.1038/nrm2977 ↗
46. 2H Nuclear magnetic resonance order parameter profiles suggest a change of molecular shape for phosphatidylcholines containing a polyunsaturated acyl chain10.1016/S0006-3495(95)80422-4 ↗
47. Ion channels: From idea to reality10.1038/13415 ↗
48. Mitochondrial ion channels: Gatekeepers of life and death10.1152/physiol.00020.2005 ↗
49. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function10.1016/0304-4157(84)90005-4 ↗
50. Phase transitions and fluidity characteristics of lipids and cell membranes10.1017/S0033583500001797 ↗
51. Regulation of phosphatidylcholine biosynthesis10.1016/0304-4157(84)90010-8 ↗
52. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells10.1016/j.bbalip.2012.08.016 ↗
53. Mattress model of lipid-protein interactions in membranes10.1016/S0006-3495(84)84007-2 ↗
54. The basic structure and dynamics of cell membranes: An update of the Singer-Nicolson model10.1016/j.bbamem.2014.01.006 ↗
55. Dynamic organizing principals of the plasma membrane that regulate signal transduction: Commemorating the fortieth anniversary of Singer and Nicolson’s fluid-mosaic model10.1146/annurev-cellbio-100809-151736 ↗
56. The mystery of membrane organization: Composition, regulation and roles of lipid rafts10.1038/nrm.2017.16 ↗
57. Sending out an SOS: Mitochondria as a signalling hub10.3389/fcell.2016.00109 ↗
58. Mitochondria, oxidants and aging10.1016/j.cell.2005.02.001 ↗
59. Mitochondrial membrane lipid 30luminium30g in pathophysiology: A new target for diet and therapeutic interventions10.1016/j.plipres.2013.06.002 ↗
60. Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications10.1016/0005-2728(96)00077-1 ↗
61. The dynamics of cardiolipin synthesis post-mitochondrial fusion10.1016/j.bbamem.2010.04.007 ↗
62. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria10.1096/fj.03-0012com ↗
63. Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function10.1074/jbc.M909868199 ↗
64. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain10.1126/science.1230381 ↗
65. Role of cardiolipin alterations in mitochondrial dysfunction and disease10.1152/ajpcell.00243.2006 ↗
66. Role of mitochondrial permeability transition pores in mitochondrial autophagy10.1016/j.biocel.2004.04.009 ↗
67. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis10.1126/science.275.5303.1132 ↗
68. A time to reap, a time to sow: Mitophagy and biogenesis in cardiac pathophysiology10.1016/j.yjmcc.2014.10.003 ↗
69. Calcium, ATP, and ROS: A mitochondrial love-hate triangle10.1152/ajpcell.00139.2004 ↗
70. Activation and regulation of the inflammasomes10.1038/nri3452 ↗
71. Of inflammasomes and apathogens—sensing of microbes by the inflammasome10.1002/emmm.201201771 ↗
72. Silica crystals and 30luminium salts activate the NALP3 inflammasome through phagosomal destabilization10.1038/ni.1631 ↗
73. The pyroptosome: A supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation10.1038/sj.cdd.4402194 ↗
74. Mitochondrial function in immune cells in health and disease10.1016/j.bbadis.2020.165845 ↗
75. Mitochondria and apoptosis10.1046/j.1432-1327.1998.2520001.x ↗
76. Mitochondria: Omega-3 in the route of mitochondrial reactive oxygen species. Intern10.1016/j.biocel.2012.06.003 ↗
77. Zeeshan, H.M.A., Lee, G.H., Kim, H.R., and Chae, H.J. (2016). Endoplasmic reticulum stress and associated ROS. Intern. J. Mol. Sci., 17.10.3390/ijms17030327 ↗
78. Mitochondrial oxidative stress and cell death in astrocytes—requirement for stored Ca2+ and susptained opening the permeability transition pore10.1242/jcs.115.6.1175 ↗
79. Distinct mPTP activation mechanisms in ischaemia–reperfusion: Contribution of Ca2+, ROS, pH and inorganic polyphosphate10.1093/cvr/cvv097 ↗
80. Khairallah, R.J., Kim, J., O’Shea, K.M., O’Connell, K.A., Brow, B.H., Galvao, T., Daneault, C., Des Rosiers, C., Polster, B.M., and Hoppel, C.L. (2012). Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids. PLoS ONE, 7.10.1371/journal.pone.0034402 ↗
81. Fat digestion by lingual lipase: Mechanism of lipolysis in the stomach and upper small intestine10.1203/00006450-198405000-00002 ↗
82. Incorporation of PPC into serum lipoproteins after oral or i.v. administration
83. Johnson, L.R. (1981). Gastrointestinal lipid digestion in physiology of the gastrointestinal tract. Physiology of the Gastrointestinal Tract, Raven Press.
84. Digestion and absorption of dietary glycerophospholipids in the small intestine: Their significance as carrier molecules of choline and n-3 polyunsaturated fatty acids10.1016/j.bcab.2020.101633 ↗
85. Fat, faeces and the importance of the ileum
86. Evolutionary origins and natural functions of fructans—A climatological, biogeographic and mechanistic appraisal10.1111/j.1469-8137.1993.tb04525.x ↗
87. Fructans insert between the headgroups of phospholipids10.1016/S0005-2736(00)00363-1 ↗
88. Visualization by freeze fracture, in vitro and in vivo of the products of fat digestion10.1016/S0022-2275(20)38788-5 ↗
89. Fine structural observations of the absorption of lipid particles in the small intestine of the rat10.1002/ar.1091520312 ↗
90. Ultrastructural changes in the microvillous plasma membrane during lipid absorption and the form of absorbed lipid: An in vitro study at 37 °C10.1016/S0022-5320(67)80101-1 ↗
91. Phosphatidylcholine as a constituent in the colonic mucosal barrier—physiological and clinical relevance10.1016/j.bbalip.2010.05.014 ↗
92. Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes10.1016/j.febslet.2009.12.049 ↗
93. Functions of phospholipid flippases10.1093/jb/mvq140 ↗
94. Non-vesicular lipid transport by lipid-transfer proteins and beyond10.1038/nrm2971 ↗
95. Phospholipids and lipid droplets10.1016/j.bbalip.2012.12.001 ↗
96. Membrane contact sites, gateways for lipid homeostasis10.1016/j.ceb.2014.12.004 ↗
97. Lipid transfer and signaling at organelle contact sites: The tip of the iceberg10.1016/j.ceb.2011.04.006 ↗
98. Lipid trafficking sans vesicles: Where, why, how?10.1016/j.cell.2010.11.031 ↗
99. Phospholipid transport and remodeling in health and disease10.4149/gpb_2011_SI1_25 ↗
100. Making heads or tails of phospholipids in mitochondria10.1083/jcb.201006159 ↗